Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Abbott Laboratories ABT

Healthcare  —  Medical Devices
101.29 0.22 0.22% as of 25 Sep
Market cap
$174.8B
P/E
32.8×
S&P 500 Member Dividend Champion (10y) Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Abbott Laboratories (ABT) Price to free cash flow

As of 25 September 2026, Abbott Laboratories (ABT) trades at a price to free cash flow of 22.5×. Over the past ten years it has ranged from 19.5× (May 2026) to 44.3× (November 2020); the current reading is higher than 9% of that period. That is in line with the Medical Devices industry median of 22.5× and above the Healthcare sector median of 19.5×.

Price to free cash flow, daily

Annual

Period Price to free cash flow Change
FY2025 29.5× (4.81%)
FY2024 31.0× (17.98%)
FY2023 37.8× 53.49%
FY2022 24.6× (14.79%)
FY2021 28.9× (14.82%)
FY2020 33.9× (0.67%)
FY2019 34.1× 31.73%
FY2018 25.9× 12.37%
FY2017 23.1× (16.74%)
FY2016 27.7× (23.47%)

Quarterly

Period Price to free cash flow Change
Jun 2026 20.2× (16.76%)
Mar 2026 24.2× (17.80%)
Dec 2025 29.5× (12.56%)
Sep 2025 33.7× (3.62%)
42 more quarters

Against its own ten years

Low 19.5× High 44.3×
Ten-year median 30.5×
Current reading's percentile 9

Price to free cash flow against peers

Company Price to free cash flow
PHG Koninklijke Philips N.V. compare 12.9×
BSX Boston Scientific Corporation compare 17.8×
MDT Medtronic PLC compare 18.5×
GEHC GE HealthCare Technologies Inc. compare 19.1×
STE STERIS plc compare 21.8×
SYK Stryker Corporation compare 22.2×
ABT Abbott Laboratories 22.5×
DXCM DexCom, Inc. compare 23.6×
EW Edwards Lifesciences Corporation compare 35.4×
Medical Devices industry median 22.5×
Healthcare sector median 19.5×
Market median 14.0×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on ABT